PHILIPS LIVE - Dallas PCI: Coronary Imaging and Physiology

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >700 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 100) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Dr. Dib is board certified in cardiovascular disease and interventional cardiology. In addition, he has completed extensive training in nuclear cardiology and is certified by the Certification Board of Nuclear Cardiology. His clinical interests include coronary artery disease and interventions, peripheral artery disease and interventions, structural heart disease, venous disease, ablation, thrombectomy, pacemaker implantation and interrogation. After finishing his internship and residency training at Mayo Clinic, Dr. Dib went on to complete a fellowship in Cardiovascular Disease at the University of Oklahoma Health Sciences Center in Oklahoma City and a fellowship in Interventional Cardiology at the University of Texas Health Science Center in Houston. He is also a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. Dr. Dib is on the medical staff at The Heart Hospital Baylor Plano and Baylor Scott & White Medical Center – McKinney. He is currently welcoming new patients.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >700 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 100) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Molly Szerlip is an interventional cardiologist.

Dr. Dib is board certified in cardiovascular disease and interventional cardiology. In addition, he has completed extensive training in nuclear cardiology and is certified by the Certification Board of Nuclear Cardiology. His clinical interests include coronary artery disease and interventions, peripheral artery disease and interventions, structural heart disease, venous disease, ablation, thrombectomy, pacemaker implantation and interrogation. After finishing his internship and residency training at Mayo Clinic, Dr. Dib went on to complete a fellowship in Cardiovascular Disease at the University of Oklahoma Health Sciences Center in Oklahoma City and a fellowship in Interventional Cardiology at the University of Texas Health Science Center in Houston. He is also a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. Dr. Dib is on the medical staff at The Heart Hospital Baylor Plano and Baylor Scott & White Medical Center – McKinney. He is currently welcoming new patients.

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.

Sameh Sayfo, MD, RPVI is an interventional cardiologist with Legacy Heart Center. He specializes in the management of cardiac diseases including atrial fibrillation, coronary artery disease, peripheral arterial and venous disease, and heart failure. His areas of expertise include complex coronary and peripheral artery interventions, atrial septal defect and patent foramen ovale closures, aortic valve treatment including valvuloplasty and transcather aortic valve replacement (TAVR), as well as endovascular aortic repair (EVAR) and carotid stenting. Dr. Sayfo is certified by the National Board of Echocardiography and he is a Registered Physician in Vascular Interpretation (RPVI) certified by the American Registry for Diagnostic Medical Sonography. He is also specially trained in venous ablation, treating venous diseases including varicose and spider veins using both endovenous laser treatment (EVLT) and radiofrequency ablation. In addition, he is active in clinical research and has a special interest in interventional cardiology studies. Dr. Sayfo is on the medical staff at The Heart Hospital Baylor Plano, Baylor Regional Medical Center at Plano, and Baylor Medical Center at McKinney. He is currently welcoming new patients.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >700 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 100) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Molly Szerlip is an interventional cardiologist.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.